Results 71 to 80 of about 6,848 (153)

The use of cladribine tablets in patients with MS beyond the age of 50: experiences from a large tertiary German centre. [PDF]

Neurol Res Pract
Axhausen F, Wolff S, Baumgart R, Arneth B, Mrochen A, Kraemer HH, Pfeuffer S.   +6 more
europepmc   +1 more source

Longitudinal and Stability-Aware Analysis Reveals Treatment-Specific MicroRNA Response Signatures Following Immune-Reconstitution and B-Cell-Targeted Therapies in Multiple Sclerosis. [PDF]

Int J Mol Sci
Ata N, Mytych JS, Cerghet M, Rattan R, Govil S, Giri S, Mao-Draayer Y.   +6 more
europepmc   +1 more source

Cladribine treatment in pediatric-onset multiple sclerosis: real-world clinical outcomes and safety insights. [PDF]

Front Immunol
Ganelin-Cohen E, Wexler Y, Kraus S, Rozenberg A.   +3 more
europepmc   +1 more source

Langerhans Cell Histiocytosis Associated With Chronic Myeloid Leukemia: A Pediatric Case Report. [PDF]

Cancer Rep (Hoboken)
Latifi A, Yousefian S.
europepmc   +1 more source

The effect of cladribine-containing conditioning regimen on the efficacy and safety of allogeneic hematopoietic stem cell transplantation for children with acute lymphoblastic leukemia. [PDF]

Stem Cell Res Ther
Li X, Hu K, Lin S, Que L, Ye Y, Han X, Wang Y, Wu X, Zhan L, Zhou D, Li Y, Zhong D, Fang J, Xu H, Huang K.   +14 more
europepmc   +1 more source

Treatment-free remission in MS: long-term disease control with cladribine tablets. [PDF]

J Neurol
Wiendl H, Gold R, Pul R, Ernst M, Kowarik MC, Klehmet J, Siglienti I, Hübschen M, Wagner T, Knaup J, Kleinschnitz C.   +10 more
europepmc   +1 more source

Hairy Cell Leukemia: Clinical Characteristics and Outcomes from a Single Center in the Middle East and North Africa. [PDF]

J Blood Med
Mohamed S, Dulli MW, Al-Mashdali A, Ghasoub R, Abdulgayoom M, Cherif H, Akiki S, Elahie A, Mudawi D, Elsabah H, Yassin M, Moustafa NS, Haj Saleh L, Vatsayana PA, Kohla S, Ibrahim F, Soliman D.   +16 more
europepmc   +1 more source

The efficacy of disease-modifying therapies in patients with clinically isolated syndrome: a systematic review and network meta-analysis. [PDF]

Sci Rep
Chumpangern Y, Seawsirikul Y, Keatbundit P, Thongtem L, Uawithya E, Khampang R, Ongphichetmetha T, Siritho S, Prayoonwiwat N, Jitprapaikulsan J.   +9 more
europepmc   +1 more source

Efficacy and safety of a new cladribine-based conditioning regimen for allogeneic hematopoietic stem cell transplantation in children with relapsed or refractory acute myeloid leukemia. [PDF]

Front Med (Lausanne)
Pei WT, Liu CL, Li XL.
europepmc   +1 more source

Hairy Cell Leukemia: A Rare Differential for an Infiltrative Pancreatic Mass. [PDF]

ACG Case Rep J
Ibrahim S, Rabeeah S, Aggarwal N, Kiros N, Jamil L.   +4 more
europepmc   +1 more source